Pacific Biosciences Of California (PACB) Inventory Average (2011 - 2026)

Pacific Biosciences Of California's Inventory Average history runs 16 years deep, the most recent figure standing at $50.2 million for Q1 2026.

• In Q1 2026, Inventory Average fell 11.05% year-over-year to $50.2 million; the TTM figure through Mar 2026 stood at $50.2 million (down 11.05% YoY), while the FY2025 annual figure was $54.0 million, down 6.4% from the prior year.
• Inventory Average was $50.2 million for Q1 2026 at Pacific Biosciences Of California, down from $51.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $68.0 million in Q2 2024 to a low of $27.1 million in Q1 2022.
• Historically, Inventory Average has averaged $54.3 million across 5 years, with a median of $56.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory Average surged 107.17% in 2023, then decreased 20.66% in 2025.
• A 5-year view of Inventory Average shows it stood at $46.9 million in 2022, then soared by 33.08% to $62.5 million in 2023, then slipped by 0.35% to $62.2 million in 2024, then declined by 17.72% to $51.2 million in 2025, then decreased by 2.08% to $50.2 million in 2026.
• The last three Inventory Average figures came in at $50.2 million (Q1 2026), $51.2 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.